HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Sandro De Falco Selected Research
Sandro De Falco Research Topics
Disease
18
Neoplasms (Cancer)
03/2024 - 08/2002
13
Pathologic Neovascularization
04/2021 - 01/2004
8
Inflammation (Inflammations)
03/2024 - 03/2008
7
Choroidal Neovascularization
04/2021 - 04/2009
5
Neoplasm Metastasis (Metastasis)
03/2024 - 03/2008
5
Ischemia
04/2021 - 08/2002
3
Colorectal Neoplasms (Colorectal Cancer)
03/2024 - 04/2015
3
Macular Degeneration (Age-Related Maculopathy)
01/2021 - 01/2016
3
Hypoxia (Hypoxemia)
05/2017 - 04/2014
3
Arthritis (Polyarthritis)
01/2010 - 01/2004
2
Diabetic Retinopathy (Retinopathy, Diabetic)
01/2021 - 02/2018
2
Retinal Diseases
01/2021 - 02/2018
2
Blindness (Hysterical Blindness)
01/2020 - 12/2012
2
Parkinson Disease (Parkinson's Disease)
01/2020 - 08/2010
2
Macular Edema
10/2019 - 11/2017
2
Rheumatoid Arthritis
03/2015 - 02/2009
2
Carcinoma (Carcinomatosis)
06/2011 - 01/2011
2
Experimental Arthritis
01/2010 - 02/2009
1
Carcinogenesis
03/2024
1
Retinopathy of Prematurity (Retrolental Fibroplasia)
01/2021
1
Pathologic Processes
01/2021
1
Retinal Vein Occlusion
02/2018
1
Vascular Diseases (Vascular Disease)
02/2018
1
Glioma (Gliomas)
05/2017
1
Autoimmune Diseases (Autoimmune Disease)
01/2016
1
Corneal Neovascularization
01/2016
1
Fibrosarcoma
01/2016
1
Ulcer
01/2015
1
T-Cell Leukemia (Leukemia, T Cell)
03/2014
1
Colonic Neoplasms (Colon Cancer)
01/2014
1
Teratocarcinoma
01/2013
1
Melanoma (Melanoma, Malignant)
06/2011
1
Peripheral Arterial Disease
03/2010
1
Intermittent Claudication
03/2010
1
Hyperplasia
01/2010
1
Breast Neoplasms (Breast Cancer)
08/2008
1
Atherosclerosis
01/2004
1
Body Weight (Weight, Body)
01/2004
Drug/Important Bio-Agent (IBA)
19
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
01/2021 - 08/2002
9
Intercellular Signaling Peptides and Proteins (Growth Factors)
IBA
02/2018 - 01/2004
5
Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)
IBA
07/2015 - 03/2008
4
Retinaldehyde (Retinal)
IBA
04/2021 - 02/2018
3
Peptides (Polypeptides)
IBA
04/2015 - 01/2010
2
Proteins (Proteins, Gene)
FDA Link
12/2023 - 05/2017
2
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
04/2021 - 02/2009
2
Vascular Endothelial Growth Factor B
IBA
01/2021 - 07/2015
2
aflibercept
IBA
10/2019 - 11/2017
2
Bevacizumab (Avastin)
FDA Link
04/2015 - 01/2014
2
Collagen Type II (Type II Collagen)
IBA
01/2010 - 02/2009
1
Biomarkers (Surrogate Marker)
IBA
03/2024
1
Inflammasomes
IBA
03/2024
1
RNA (Ribonucleic Acid)
IBA
03/2024
1
Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)
IBA
04/2021
1
Ligands
IBA
01/2021
1
Antibodies
IBA
12/2020
1
Synucleins
IBA
01/2020
1
Glucose (Dextrose)
FDA Link
Generic
10/2019
1
Prostaglandins F
IBA
02/2018
1
Oxygen (Dioxygen)
IBA
02/2018
1
Transcription Factors (Transcription Factor)
IBA
05/2017
1
Intravenous Immunoglobulins (IVIG)
FDA Link
01/2016
1
Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)
IBA
07/2015
1
Monoclonal Antibodies
IBA
04/2015
1
Irinotecan (Camptosar)
FDA Link
Generic
04/2015
1
Nitric Oxide (Nitrogen Monoxide)
FDA Link
01/2015
1
Antioxidants
IBA
01/2015
1
Histones (Histone)
IBA
04/2014
1
Thioredoxins
IBA
03/2014
1
atractyligenine
IBA
03/2014
1
ent-kaurane 15-ketoatractyligenin methyl ester
IBA
03/2014
1
nutlin 3
IBA
10/2013
1
entinostat (MS 275)
IBA
01/2013
1
Therapeutic Uses
IBA
01/2013
1
Histone Deacetylase Inhibitors
IBA
01/2013
1
Angiogenesis Inhibitors
IBA
07/2011
1
amentoflavone
IBA
06/2011
1
Carnitine (L-Carnitine)
FDA Link
Generic
03/2010
1
Vascular Endothelial Growth Factor Receptors (VEGF Receptors)
IBA
01/2010
1
Autoantibodies
IBA
01/2010
1
Neuropilin-1
IBA
01/2010
1
Toll-Like Receptor 3
IBA
04/2009
1
Double-Stranded RNA (RNA, Double Stranded)
IBA
04/2009
1
Small Interfering RNA (siRNA)
IBA
04/2009
1
Cytokines
IBA
02/2009
1
Placenta Growth Factor
IBA
02/2009
1
Interleukin-6 (Interleukin 6)
IBA
02/2009
1
ErbB Receptors (EGF Receptor)
IBA
08/2008
1
Phosphotransferases (Kinase)
IBA
08/2008
1
vandetanib (ZD6474)
IBA
08/2008
1
Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)
IBA
05/2006
1
Citrate (si)-Synthase (Synthase, Citrate)
IBA
01/2004
1
Protein-Tyrosine Kinases (Tyrosine Kinase)
IBA
01/2004
Therapy/Procedure
6
Lasers (Laser)
04/2021 - 12/2012
5
Therapeutics
01/2020 - 08/2010
1
Precision Medicine
12/2023
1
Intravitreal Injections
04/2015
1
Subcutaneous Injections
01/2010
1
Sutures (Suture)
04/2009